Publications by authors named "Zoe Betteridge"

Claim this Profile
R
Revisiting the link between oropharyngeal dysphagia and cancer in autoimmune myositis: a descriptive study.
Hao Cheng Shen, Océane Landon-Cardinal, Josiane Bourré-Tessier, Sabrina Hoa, Farah Zarka, Zoe Betteridge

Arthritis Res Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of connective tissue disease autoantibodies and a novel autoantibody anti-annexin A11 in patients with "idiopathic" interstitial lung disease.
Sarah L Tansley, Fionnuala McMorrow, Caroline V Cotton, Huzaifa Adamali, Shaney L Barratt, Zoe E Betteridge

Clin Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies.
Michael Mahler, Zoe Betteridge, Chelsea Bentow, Michaelin Richards, Andrea Seaman

Front Immunol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity.
Sarah L Tansley, Danyang Li, Zoe E Betteridge, Neil J McHugh

Rheumatology (Oxford)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The myositis clinical phenotype associated with anti-Zo autoantibodies: a case series of nine UK patients.
Sarah L Tansley, Zoe Betteridge, Hui Lu, Emma Davies, Simon Rothwell

Rheumatology (Oxford)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis.
Zoe Betteridge, Hector Chinoy, Jiri Vencovsky, John Winer, Kiran Putchakayala

Rheumatology (Oxford)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis: Reply.
Alexander Oldroyd, Jamie C Sergeant, R Paul New, Neil J McHugh, Zoe Betteridge

Rheumatology (Oxford)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups.
Simon Rothwell, Hector Chinoy, Janine A Lamb, Frederick W Miller, Lisa G Rider, Zoe E Betteridge

Ann Rheum Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis.
Alexander Oldroyd, Jamie C Sergeant, Paul New, Neil J McHugh, Zoe Betteridge

Rheumatology (Oxford)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort.
Matthew J S Parker, Alexander Oldroyd, Mark E Roberts, James B Lilleker, Zoe E Betteridge

Rheumatology (Oxford)· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna .
James B Lilleker, Jiri Vencovsky, Guochun Wang, Lucy R Wedderburn, Louise P Diederichsen, Zoe Betteridge

Ann Rheum Dis· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer.
Zoe E Betteridge, Lynsey Priest, Robert G Cooper, Neil J McHugh, Fiona Blackhall

Arthritis Res Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis.
John D Pauling, Gloria Salazar, Hui Lu, Zoe E Betteridge, Shervin Assassi

Rheumatology (Oxford)· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EuroMyositis registry: an international collaborative tool to facilitate myositis research.
James B Lilleker, Jiri Vencovsky, Guochun Wang, Lucy R Wedderburn, Louise Pyndt Diederichsen, Zoe E Betteridge

Ann Rheum Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.
Sarah L Tansley, Stefania Simou, Gavin Shaddick, Zoe E Betteridge, Beverley Almeida

J Autoimmun· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.
Sarah L Tansley, Zoe E Betteridge, Stefania Simou, Thomas S Jacques, Clarissa Pilkington

J Rheumatol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis and dermatomyositis.
Louise Ekholm, J Michelle Kahlenberg, Sevim Barbasso Helmers, Anna Tjärnlund, Srilakshmi Yalavarthi, Zoe Betteridge

Rheumatology (Oxford)· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.
Claire T Deakin, Shireena A Yasin, Stefania Simou, Katie A Arnold, Sarah L Tansley, Zoe E Betteridge

Arthritis Rheumatol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Anti-Eukaryotic Initiation Factor 2B Autoantibodies Are Associated With Interstitial Lung Disease in Patients With Systemic Sclerosis.
Zoe E Betteridge, Felix Woodhead, Hui Lu, Gavin Shaddick, Christopher C Bunn

Arthritis Rheumatol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathies.
Joanna E Parkes, Simon Rothwell, Philip J Day, Neil J McHugh, Zoë E Betteridge

Arthritis Res Ther· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.
Martin Klein, Heřman Mann, Lenka Pleštilová, Josef Zámečník, Zoe Betteridge

Rheumatology (Oxford)· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Comparison of clinical characteristics and laboratory parameters of patients with dermatomyositis-specific autoantibodies and autoantibody-negative patients].
Levente Bodoki, Dóra Budai, Melinda Nagy-Vincze, Zoltán Griger, Zoe Betteridge

Orv Hetil· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
Levente Bodoki, Melinda Nagy-Vincze, Zoltán Griger, Zoe Betteridge, Lászlóné Szöllősi

Autoimmun Rev· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Risk factors for cancer in patients with myositis. Clinical, immunological characteristics and the role of the anti-p155/140 antibody].
Zsuzsanna Szankai, Melinda Nagy-Vincze, Levente Bodoki, András Jakab, Zoe Betteridge

Orv Hetil· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study.
Sarah L Tansley, Zoe E Betteridge, Harsha Gunawardena, Thomas S Jacques, Catherine M Owens

Arthritis Res Ther· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis